RxDoctor Payments DataLook up a doctor →

Malisa Agard

Internal Medicine · Orlando, FLNPI 1366708323

Payments from drug & device makers

$12,190,764in general payments, 2019–2025

Across 445 payments — averaging $27,395 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6.5M
  • Amgen$1.5M
  • Genentech, Inc.$1.2M
  • Eisai Inc.$1.1M
  • Pfizer$891K
  • Boehringer Ingelheim International GmbH$268K
  • plus $716K from 14 others
$109,834in research payments, 2019–2025

Across 8 payments — averaging $13,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$110K
  • Novo Nordisk AS$118

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,190,764 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →